etoposide has been researched along with nu 7026 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Binet, JL; Delic, J; Deriano, L; Favaudon, V; Guipaud, O; Maciorowski, Z; Merle-Béral, H; Muller, C; Potocki-Veronese, G; Ricoul, M; Sabatier, L; Salles, B | 1 |
Borda, MA; de Campos Nebel, M; González-Cid, M; Palmitelli, M; Verón, G | 1 |
2 other study(ies) available for etoposide and nu 7026
Article | Year |
---|---|
Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway.
Topics: Androstadienes; Antibiotics, Antineoplastic; Antigens, Nuclear; Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Blotting, Western; Cell Line, Transformed; Cell Line, Tumor; Cell-Free System; Chromones; Dimerization; DNA; DNA Damage; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Gamma Rays; Humans; Ku Autoantigen; Leukemia, Lymphocytic, Chronic, B-Cell; Morpholines; Okadaic Acid; Phosphatidylinositol 3-Kinases; Protein Binding; Telomere; Time Factors; Wortmannin; Zinostatin | 2005 |
Tyrosyl-DNA-phosphodiesterase I (TDP1) participates in the removal and repair of stabilized-Top2α cleavage complexes in human cells.
Topics: Antigens, Neoplasm; Chromones; Colony-Forming Units Assay; DNA Damage; DNA End-Joining Repair; DNA Primers; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Gentian Violet; HeLa Cells; Histones; Humans; Immunoblotting; Micronucleus Tests; Morpholines; Phosphoric Diester Hydrolases; Poly-ADP-Ribose Binding Proteins; Real-Time Polymerase Chain Reaction | 2015 |